Darnitsa Becomes the First Ukrainian-Based Pharmaceutical Company to Implement Freyr’s AMS with Integrated GlobalVision Verify Tool


Posted December 22, 2021 by freyrsolutions

Freyr, a leading global Regulatory solutions and service provider, is pleased to announce the partnership with Darnitsa, a Ukrainian-based pharmaceutical company, offering Artwork Management System (AMS)

 
"New Jersey, Dec 15, 2021: Freyr, a leading global Regulatory solutions and service provider, is pleased to announce the partnership with Darnitsa, a Ukrainian-based pharmaceutical company, offering Artwork Management System (AMS). This marks Darnitsa as the first Ukrainian Pharmaceutical company to implement Freyr’s AMS integrated with the GlobalVision Verify tool.

As part of the partnership, Freyr provides Artwork management solution, from creation to email notifications to online approvals, and GlobalVision Verify, a web-based proofreading tool, fits in the Freyr’s AMS for simultaneous and automated inspections at every revision point.

Sathya K, Vice President, Regulatory Operations at Freyr, said, “we believe that digitalization is the steppingstone for innovation. This new deployment of the next-gen AMS paves the way for significantly improving the right-first-time artwork management. Driving digital transformation in the Regulatory processes has always been our priority, and we are excited to partner with Darnitsa and accelerate their Artwork management strategies."
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By 12-15-2021
Phone 9084837958
Business Address NJ, USA
Country United States
Categories Biotech
Tags artwork management system ams , artwork management solution
Last Updated December 22, 2021